# Efficacy of G-CSF-Priming in Elderly AML Patients

> **NCT00199147** · PHASE4 · UNKNOWN · sponsor: **Johann Wolfgang Goethe University Hospital** · enrollment: 250 (—)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Cytarabine
- **DRUG:** Etoposide
- **DRUG:** Idarubicin
- **DRUG:** G-CSF
- **DRUG:** Fludarabine
- **PROCEDURE:** Stem cell apheresis
- **PROCEDURE:** Stem cell transplantation

## Key facts

- **NCT ID:** NCT00199147
- **Lead sponsor:** Johann Wolfgang Goethe University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 250 (—)
- **Last updated:** 2005-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00199147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00199147, "Efficacy of G-CSF-Priming in Elderly AML Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00199147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*